Important Note: This document is a subjective research brief — not a binding plan. All projections, cost estimates, team structures, and timelines are directional and subject to change. IntakeIQ is being built primarily through AI-assisted autonomous development (A.X.I.S.), which dramatically reduces the need for traditional hiring. Most functions described as "team roles" below will be automated or handled by the founding team with AI tooling — not by hiring employees or contractors.
1. Market Size & Opportunity
$179B
US Dental Services Market (2026)
$2.6B
Dental Practice Mgmt Software (2026)
178,000
Dental Practice Businesses (US)
200,000+
Active Dentists (US)
Total Addressable Market (TAM) Breakdown
| Layer | Size | Source / Basis |
|---|
| US Dental Services Market | $179.4B (2026) | IBISWorld, Precedence Research, NovaOne Advisor |
| Global Dental Practice Mgmt Software | $2.36-3.18B (2025) | Mordor Intelligence, Precedence Research |
| Projected DPMS Market (2031) | $4.44B | Mordor Intelligence (11.12% CAGR) |
| Projected DPMS Market (2035) | $8.2-8.3B | Precedence Research (10.06% CAGR) |
| SaaS Share of DPMS | 60.5% of revenue (2025) | Industry reports; growing at 13.85% CAGR |
| US Dental Software Market | ~$1.1-1.4B (implied, 45% of global) | North America = 45.13% of global DPMS revenue |
IntakeIQ Serviceable Market Sizing
| Segment | Count | IntakeIQ ACV | SAM |
|---|
| Independent practices (1-5 locations) still on paper/basic digital intake | ~98,000 practices (82% of 120K) | $3,348/yr (Professional plan) | $328M |
| Emerging DSOs (10-50 locations) | ~300+ DSOs, ~8,000 locations | $4,188+/yr per location | $33.5M+ |
| Large DSOs (50+ locations) | ~100+ DSOs, ~11,500+ locations under DSO mgmt | Custom pricing | $48M+ (at $4,188 floor) |
Bottom-up SAM estimate: ~$400M+ for dental intake automation specifically, assuming 82% of practices still use paper/basic intake and the average practice would pay $3,300-$4,200/year for an AI-powered intake solution. This is a subset of the $2.6B dental practice management software market.
DSO Consolidation Tailwind
- 39% of dental offices will be DSO-affiliated by 2026, up from 23% in 2024 -- a massive acceleration
- US DSO market valued at $52.4B (2026), growing at 17.5% CAGR to $223B by 2035
- Over 300 DSOs operate nationwide; corporate-owned DSOs with 50+ locations control 41% of the US market
- DSOs are the ideal buyer: they need standardized intake across locations, have budget, and move faster than solo practices
2. Competitor Deep Dive
Verified financial data, funding rounds, pricing, and market position for every relevant competitor.
Public (NYSE: WEAV)
Weave Communications
| Revenue (FY2025) | $239.0M (+17% YoY from $204.3M in 2024) |
| Q4 2025 Revenue | $63.4M (+17% YoY) |
| Market Cap | ~$1.2B (fluctuating) |
| Customers | 30,000+ customers, ~40,000 locations |
| Employees | 904 |
| Net Loss (FY2025) | -$28.1M (accumulated deficit: $319.1M) |
| Free Cash Flow | $12.9M (first meaningful positive FCF) |
| Pricing | $400-$750/mo (bundle-dependent) |
| Intake Capability | Basic digital forms bolted onto comms platform. No AI, no OCR, no eligibility. |
| Implied ACV | ~$8,000/customer ($239M / 30K customers) |
VC-Backed Unicorn
NexHealth
| Total Funding | $177M (Series A through C) |
| Last Round | Series C: $125M (April 2022) |
| Valuation | $1.0B (unicorn status at Series C) |
| Lead Investor | Andreessen Horowitz (a16z) |
| Employees | ~209 (Jan 2026) |
| ARR | Not publicly disclosed. Estimated $40-60M based on headcount/burn benchmarks. |
| Pricing | $350-$550/mo |
| Intake Capability | Template-based digital forms. No AI, no OCR, no eligibility verification, no adaptive logic. |
Public (NYSE: PHR)
Phreesia
| Revenue (FY2025) | $419.8M (+18% YoY) |
| FY2026 Guidance | $472-482M (recently cut near-term outlook) |
| Market Cap (Mar 2026) | ~$689M (stock under pressure, down from $2.3B+ peak) |
| Clients | 4,203 average healthcare services clients (FY2025, +17% YoY) |
| Pricing | $500+/mo (enterprise-oriented) |
| Dental Vertical | Exists but is secondary. Built for medical; dental is an adaptation. CDT codes, dental insurance structures, frequency limitations are not native. |
| Note | Still publicly traded (NYSE: PHR). NOT acquired by TPG -- this was previously misreported in IntakeIQ materials. Needs correction. |
Incumbent (NASDAQ: HSIC)
Dentrix / Dentrix Ascend (Henry Schein One)
| Parent Revenue | Henry Schein total: $13.2B (FY2025). Global Dental: $6.87B (+2.8% YoY). |
| Technology Segment Growth | +9.7% (Q3 2025); cloud subscribers up 20% YoY to 10,500+ |
| Practices Served | 48,000+ practices (Dentrix + Dentrix Ascend) |
| DSO Penetration | 90% of top 50 DSOs use Dentrix |
| PMS Market Share | ~35% of US dental PMS market |
| Pricing | $400-$700/mo + per-provider fees |
| Intake Capability | eClipboard: tablet-based, in-office only. No SMS, no AI, no OCR. Acquired Jarvis Analytics (March 2024) for predictive models. |
Open Source PMS
Open Dental
| Pricing | $179/mo (support plan); free self-hosted option |
| Market Position | Most integration-friendly PMS. Open API. Strong developer community. |
| Intake Capability | eClipboard: basic, in-office tablet only. No pre-visit, no AI, no OCR. |
| IntakeIQ Relevance | Best first integration target due to open API and tech-forward user base. |
Bootstrapped / Lightly Funded
Yosi Health
| Revenue (2024) | $7.5M |
| Funding | Minimal: ~$140K-$650K seed (2016). No subsequent rounds disclosed. |
| Employees | 81 |
| Investors | Dreamit Ventures, Plug and Play Tech Center, StartUp Health, VentureHealth |
| Recognition | Best in KLAS 2024 (Patient Intake Management). MedTech Breakthrough 2025 winner. |
| Pricing | Not publicly listed. Estimated $250-$400/mo based on market positioning. |
| Intake Capability | Cloud-based mobile patient intake and registration. Not dental-specific -- general healthcare. No AI, no OCR, no eligibility automation. |
Series B Cloud PMS
tab32
| Revenue (2024) | $3.9M (up from $2.6M in 2023; +50% YoY) |
| Funding | Series B (undisclosed amount). 5 consecutive years of 100% YoY growth. Two straight years profitable. |
| Investors | Spark Growth Ventures (Series B lead), JBV Capital, EvoNexus |
| Platform Scale | 7.3M patients, 9.3M appointments, 100M+ radiology X-rays tracked. $375M annual revenue flowing through platform. |
| Pricing | Custom (DSO volume pricing) |
| Intake Capability | Basic digital forms within PMS. Not focused on patient-side intake experience. |
Cloud PMS
Curve Dental
| Investment | $60M reinvestment into SuperHero platform over 3 years (internal, not VC round) |
| Funding | Private; no recent VC rounds disclosed |
| Product | Cloud-native PMS (Curve Hero, Curve SuperHero). Integrated with Mango Voice for AI-powered call documentation. |
| Pricing | Not publicly listed. Market positioning suggests $300-$500/mo range. |
| Intake Capability | Basic digital forms within the PMS. Not a standalone intake product. |
Competitor Funding Summary
| Company | Total Raised / Status | Last Round | Key Investors | Revenue |
|---|
| Weave | IPO (NYSE: WEAV) | IPO Nov 2021 | Public markets; Tiger Global, Catalyst | $239M (2025) |
| NexHealth | $177M | $125M Series C (Apr 2022) | Andreessen Horowitz (a16z) | ~$40-60M est. |
| Phreesia | IPO (NYSE: PHR) | IPO Jul 2019 | Public markets | $420M (FY2025) |
| Dentrix | Henry Schein subsidiary | N/A (HSIC: $13.2B rev) | N/A | ~$500M+ est. (tech segment) |
| Yosi Health | ~$140K-$650K | Seed (2016) | Dreamit, Plug and Play, StartUp Health | $7.5M (2024) |
| tab32 | Series B (undisclosed) | Series B (2021) | Spark Growth Ventures, JBV Capital | $3.9M (2024) |
| Curve Dental | Private ($60M reinvestment) | N/A | Private | Not disclosed |
Key insight: No competitor has raised venture capital specifically for AI-powered dental intake. NexHealth raised for broad patient engagement. Weave raised for communications. Phreesia raised for medical intake (not dental). The "AI-native, dental-specific intake" category has zero funded entrants. IntakeIQ would be the first.
3. Dental Practice Economics
$700K-$1.2M
Average Annual Practice Revenue
8-12
Patients Per Day (Optimal)
$19-$25/hr
Front Desk Hourly Wage
15-20 min
Manual Intake Time Per Patient
Practice Revenue Benchmarks
- Average GP practice: $600K-$1.2M annually ($65K-$120K/month gross production)
- Specialty practices: Can significantly exceed $1M (orthodontics, oral surgery, endodontics)
- Staffing costs: 25-30% of practice overhead (the largest single expense line)
- Technology budget: $9,600-$14,400/year in software subscriptions; $21K-$50K/year in total technology spending
Front Desk Staff Economics
| Metric | National Average | California / High-COL |
|---|
| Median Hourly Wage | $19.35-$25.43/hr | $28/hr |
| Median Annual Salary | $41,280-$45,000 | $56,000 |
| Fully Loaded Cost (benefits, taxes) | ~$52,000-$58,000 | ~$72,000 |
| % Time Spent on Intake/Verification | Estimated 30-40% for new patients | Same |
The ROI Argument for Automation
Claim Denial Economics -- The Real Money
- Nearly 1 in 5 dental claims (20%) are denied on first submission
- Denials cost practices 5-10% of annual revenue ($35K-$120K/year for an average practice)
- Reworking a denied claim costs 3-5x more than getting it right the first time
- 71% of practices identify real-time insurance verification as a challenge
- Real-time eligibility verification can reduce denials by up to 18%; strong verification reduces them by 50-70%
- Average claim value: ~$285
IntakeIQ ROI Model (Typical Practice: 15 new patients/week)
| Metric | Before IntakeIQ | After IntakeIQ | Impact |
|---|
| Intake time per patient | 15-18 min | 3-5 min | ~12 min saved/patient |
| Annual intake hours (new patients) | ~234 hrs | ~46 hrs | ~188 hrs saved |
| Front desk labor saved | -- | -- | $3,700-$4,700/yr |
| Claim denial rate | 10-20% | 3-5% | $15K-$50K+ recovered/yr |
| IntakeIQ cost | -- | $3,348/yr | -- |
| Net annual benefit | -- | -- | $15K-$50K+/yr |
| ROI | -- | -- | 5-15x the subscription cost |
The pitch writes itself: "$279/month to save $15K-$50K/year in denied claims and staff time. Payback period: weeks. ROI: 500-1,500%." This is a no-brainer sale for any practice losing money to intake errors and denials.
4. Dental SaaS Funding Landscape
Macro Environment
- Dental tech sector raised $2.1B in 2025 (+18% from 2024)
- DSO consolidation drove ~50% of that capital
- AI diagnostics, digital lab workflows, and DSO-enabling software raised the most in early 2026
- Oral health VC is still only 0.86% of global VC (2024), meaning the sector is relatively underpenetrated by venture
Notable Recent Dental Tech Funding Rounds
| Company | Round | Amount | Lead Investor | Year | Focus |
|---|
| NexHealth | Series C | $125M | Andreessen Horowitz | 2022 | Patient engagement platform |
| Tend | Series D | $125M | Oak HC/FT | 2025 | Modern dental practice chains |
| Dental Intelligence | Growth | $85M | Summit Partners | 2025 | Practice analytics |
| Pearl | Series B | $40M | Morpheus Ventures | 2025 | AI dental diagnostics |
| Candid | Growth | $75M | Foundation Capital | 2025 | DTC aligners |
| Overjet | Growth | $35M | Lightspeed Venture Partners | 2026 | AI dental insurance/treatment |
Key Dental Tech Investors to Target
Tier 1: Active Dental Tech Investors
- Andreessen Horowitz (a16z) -- Led NexHealth Series C
- Oak HC/FT -- Led Tend Series D; healthcare-focused
- Summit Partners -- Led Dental Intelligence growth round
- Lightspeed Venture Partners -- Led Overjet growth round
- Morpheus Ventures -- Led Pearl Series B
Tier 2: Healthcare SaaS Investors
- General Catalyst -- Active in healthtech SaaS
- Bessemer Venture Partners -- Healthcloud thesis
- Insight Partners -- Growth-stage healthcare software
- Spark Growth Ventures -- Led tab32 Series B
- Foundation Capital -- Led Candid round
Fundraising angle: "AI-powered dental intake" has zero funded startups. Pearl raised $40M for AI diagnostics. Overjet raised $35M for AI insurance/treatment. IntakeIQ targets the AI intake gap -- a natural complement to both. The dental AI theme has VC momentum.
5. Go-to-Market for Dental SaaS
How Successful Dental SaaS Companies Acquire Customers
Channel 1: Dental Conferences
The primary B2B sales channel for dental software. Key 2026 events:
- ADA 2026 Scientific Session (replacing SmileCon) -- Oct 8-10, Indianapolis. 30,000+ attendees. Last SmileCon ever (ADA is sunsetting the brand). Booth: $15K-$50K.
- Greater New York Dental Meeting (GNYDM) -- Nov/Dec. 50,000+ attendees. Major East Coast event.
- Chicago Dental Society Midwinter Meeting -- Feb. 30,000+ attendees.
- Hinman Dental Meeting -- March. Atlanta. 25,000+ attendees.
- DSO Summit / DEO Summit -- DSO-specific. 200+ DSOs, investors, tech vendors. High-value leads.
Channel 2: State Dental Associations
The most trusted channel for independent practices. 50 state associations with newsletters, CE programs, vendor directories, and annual meetings. An endorsement from a state association is the single most credible signal for a solo dentist.
- CDA (California), NYSDA (New York), TDA (Texas) are the largest
- Endorsement programs vary; some charge, some take revenue share
- ADA Seal of Acceptance is the gold standard (12-24 month process)
Channel 3: DSO Partnerships
Longer sales cycle (3-6 months) but massive LTV. DSOs are consolidating rapidly (39% of practices by 2026). A single DSO deal can mean 10-50+ locations overnight.
- Sell through pilot programs (3-5 locations, 30-60 days)
- ROI documentation is mandatory
- Enterprise features (SSO, multi-location dashboard, SLA) are table stakes
Channel 4: PMS Integration Marketplace
Being listed in Open Dental's integration directory or Dentrix's marketplace puts you in front of existing customers. Weave and NexHealth both grew significantly through PMS integration channels.
- Open Dental has the most open API -- best first target
- Dentrix Ascend marketplace is growing (10,500+ cloud subscribers)
- Integration = distribution
Channel 5: Dental Supply Reps
Henry Schein and Patterson Companies have field sales forces that visit every dental practice in America. They sell supplies AND software. Partnership or referral agreements with these reps can unlock massive distribution.
- Henry Schein has ~19,000 field sales consultants globally
- Patterson has ~4,700 employees in dental
- Risk: these companies also own competing software (Dentrix, Eaglesoft)
Channel 6: Digital / Content / PLG
Bottom-up growth via dental Facebook groups, dental TikTok influencers, SEO for "dental intake software," and product-led growth (free trial, self-serve onboarding). Lower cost but slower.
- Dental professionals are active on Facebook Groups (Dental Nachos, Dental Office Managers, etc.)
- SEO for "dental patient intake" is low competition
- Interactive demo / ROI calculator as lead magnet
6. 60-Day Launch Economics
What it realistically costs to go from current MVP state to first paying customers in 60 days.
Current Product State (Honest Assessment)
What exists: Full patient intake UI (7 steps, conversational, animations), office dashboard prototype, API route scaffolding, database schema (Prisma + SQLite), HIPAA security middleware, PHI encryption, audit logging framework, QR code generator, ROI calculator, demo mode with seed data.
What does NOT exist: Authentication, database persistence (API routes have TODO comments), real OCR (simulated), real insurance eligibility verification, PMS integrations, SMS/email delivery, Stripe billing, production deployment. These are the critical path items.
Critical Path to First Revenue (60 Days)
| Week | Milestone | Effort |
|---|
| 1-2 | Authentication (NextAuth) + connect API routes to database (Prisma/PostgreSQL) | Founders + A.X.I.S. |
| 2-3 | AWS Textract OCR integration (replace simulator) + HIPAA-eligible S3 for card images | Founders + A.X.I.S. |
| 3-4 | Stripe billing integration + landing page with signup flow | Founders + A.X.I.S. |
| 4-5 | Twilio SMS/email delivery for intake links + basic Open Dental API integration | Founders + A.X.I.S. |
| 5-6 | Production deployment on AWS (HIPAA-eligible) + BAA execution with subprocessors | Founders + A.X.I.S. |
| 6-7 | Beta testing with 3-5 friendly practices (free pilot) | Founders |
| 7-8 | Iterate on feedback, fix bugs, optimize intake flow | Founders + A.X.I.S. |
| 8+ | Convert pilots to paid. First revenue. | Sales + support |
Minimum Viable Team (60-Day Sprint)
Note: The table below shows a traditional VC-benchmark team structure. In practice, IntakeIQ is being built by the founding team using AI-assisted development (A.X.I.S. + Claude Code), which eliminates the need for hired developers or contractors. All engineering, DevOps, and design work is handled by the founders with AI tooling.
| Function | How We're Handling It | Traditional Cost | Our Actual Cost |
|---|
| Full-Stack Development (Next.js/React/Node) | Founder + A.X.I.S. autonomous development | $24K-$36K | $0 |
| Backend/DevOps (AWS HIPAA, Prisma, APIs) | Founder + A.X.I.S. autonomous development | $20K-$30K | $0 |
| Sales, Product, QA, Operations | Founding team (Peter Ferrante, Perri Corsello) | $0 (sweat equity) | $0 |
| Clinical Advisory | Dr. Michael Corsello — advisor | N/A | $0 |
Hard Costs (60-Day Budget)
Note: Because development is handled in-house via AI-assisted tooling, the $30K-$60K contractor line item that a traditional startup would need is eliminated. Our actual budget is infrastructure and services only.
| Item | Cost | Notes |
|---|
| Development labor | $0 | Handled by founders + A.X.I.S. (traditional estimate: $30K-$60K) |
| AWS infrastructure (HIPAA-eligible) | $500-$1,500 | RDS PostgreSQL, S3, KMS, CloudWatch. Low at launch scale. |
| Anthropic Claude API | $200-$500 | Medical history analysis. Low volume initially. |
| AWS Textract (OCR) | $100-$300 | $1.50/page. Low volume initially. |
| Twilio (SMS) | $100-$200 | ~$0.0079/SMS. Low volume. |
| Stripe fees | 2.9% + $0.30/txn | Only when revenue starts |
| Domain + SSL + basic hosting | $100-$200 | Already have most of this |
| HIPAA compliance (BAAs, legal review) | $2K-$5K | BAA templates + attorney review |
| Stripe Atlas or LLC formation | $500-$1K | If not already formed |
| Total 60-Day Budget | $3.5K-$9K | Infrastructure + services only (no hiring needed) |
Our Path: AI-First Development
IntakeIQ is being built using A.X.I.S. (Adaptive Execution Intelligence System) — an autonomous development framework that handles full-stack engineering, documentation, compliance frameworks, and infrastructure. This is not a hypothetical "if founder can code" scenario — this is how the product is already being built. The entire platform, every API route, every document, every deployment configuration was built this way. Hard costs are $3.5K-$9K for infrastructure, APIs, and legal only.
Realistic timeline adjustment: Industry benchmarks suggest 90 days for a HIPAA-compliant SaaS MVP with EHR/PMS integration, not 60. Getting the intake flow + billing live in 60 days is achievable. Getting a production-grade Open Dental integration in 60 days is aggressive. Recommendation: launch with manual PMS data entry (CSV export) in 60 days, ship the API integration at 90 days.
7. Revenue Models & Pricing Benchmarks
How Dental SaaS Companies Price
| Model | Examples | Pros | Cons |
|---|
| Per Location / Flat Monthly | Weave, NexHealth, IntakeIQ | Simple to understand, predictable for buyer | Leaves money on table for large practices |
| Per Provider | Dentrix (add-on fees), Phreesia | Scales with practice size | Harder to sell; feels like it penalizes growth |
| Per Patient / Transaction | Phreesia (per-patient-visit model) | Aligns cost with value delivered | Unpredictable for buyer; requires volume |
| Tiered Feature | IntakeIQ (Starter/Pro/Enterprise) | Clear upgrade path; good for PLG | Requires careful feature gating |
| Platform + Usage | Weave (base + add-ons) | Higher ACV; captures expansion revenue | Complex; buyers dislike surprise charges |
ACV Benchmarks by Segment
| Segment | Typical ACV Range | IntakeIQ Pricing | Competitive Position |
|---|
| Solo Practice (1 provider) | $2,400-$6,000/yr | $2,388/yr (Starter) | Low end -- good entry price |
| Group Practice (2-5 providers) | $4,000-$9,000/yr | $3,348/yr (Professional) | Below market -- value positioning |
| Small DSO (10-50 locations) | $40K-$200K/yr total | $4,188+/yr per location | Competitive at per-location level |
| Large DSO (100+ locations) | $200K-$1M+/yr | Custom | Volume discounts expected |
Comparable ACV Data (Public/Known)
- Weave: ~$8,000 implied ACV ($239M revenue / 30K customers)
- Phreesia: ~$100K implied ACV ($420M revenue / 4,203 clients) -- but serves large health systems
- NexHealth: ~$4,200-$6,600/yr ($350-$550/mo)
- Yosi Health: ~$3,000-$4,800/yr estimated ($250-$400/mo)
- IntakeIQ Professional: $3,348/yr -- intentionally priced below NexHealth and Weave to win on value
Pricing strategy note: IntakeIQ's $199-$349/mo pricing is strategically positioned below NexHealth ($350-$550) and well below Weave ($400-$750). This is the right move for market entry. As the product matures and adds PMS integrations, there is significant room to raise prices toward $400-$500/mo without losing competitive positioning. The expansion revenue from Starter-to-Professional-to-Enterprise upsell path is the real growth engine.
8. VC Assessment Summary
The Bull Case
- Massive underserved market: 82% of 120K+ dental practices still use paper intake. The problem is real and universally acknowledged.
- Unoccupied quadrant: No funded company is building AI-native, dental-specific intake automation. The positioning map has an empty slot.
- Compelling unit economics: 5-15x ROI for the customer. $279/mo to save $15K-$50K/yr. Sells itself with an ROI calculator.
- DSO consolidation tailwind: 39% DSO affiliation by 2026 and growing. DSOs need standardized intake across locations.
- AI momentum in dental: Pearl ($40M), Overjet ($35M), Dental Intelligence ($85M) all raised in 2025-2026 for dental AI. Investor appetite is proven.
- Extremely low entry cost: $3.5K-$9K to launch MVP (no hiring needed — AI-assisted development). This is one of the most capital-efficient opportunities in healthcare SaaS.
- Integration moat: Once embedded in a practice's PMS workflow, switching costs are high. Data flywheel improves OCR and AI over time.
The Bear Case
- Solo founder, pre-revenue, multiple ventures: Peter is building 4+ companies simultaneously. Focus and velocity are concerns for any investor.
- AI-assisted development for HIPAA software: The platform is built using autonomous AI development (A.X.I.S.), which is powerful but HIPAA compliance still requires deep security expertise and third-party validation. A compliance failure is existential.
- Feature claims vs. reality: Marketing materials claim 14/14 features. Actual product has TODO comments in critical paths (auth, database persistence, OCR, eligibility). The gap between pitch deck and production is significant.
- PMS integration is the real moat -- and it's not built: Dentrix and Eaglesoft have proprietary APIs. Open Dental is open, but the integration is not implemented. Without PMS sync, the product is a standalone form builder.
- Incumbents can copy fast: Henry Schein (48,000 practices, $6.87B dental revenue) could add AI to eClipboard in 6-12 months if the market proves out. Dentrix Ascend already added Jarvis Analytics AI.
- Weave and NexHealth have distribution: Weave has 40,000 locations. NexHealth has a16z backing. If either adds AI intake, they have instant distribution advantage.
- HIPAA compliance cost: SOC 2 Type II audit alone costs $20K-$75K. BAAs, penetration testing, and ongoing monitoring add up. Bootstrapping HIPAA compliance is hard.
Verdict
The opportunity is real. The market timing is right. The positioning is smart. The question is not "is this a good market?" (it clearly is) but "can this team execute?" The founding team is already building the full platform using AI-assisted autonomous development at a fraction of traditional cost. Next milestones for fundability: (1) at least 5 pilot practices with measurable results, (2) a working production deployment with real HIPAA compliance, (3) first revenue from founding cohort customers, and (4) clinical validation from advisor network. Get those four things, and this becomes a fundable seed-stage company in a $400M+ SAM with clear AI differentiation and strong unit economics.